|Bid||4.8000 x 1000|
|Ask||4.8100 x 1400|
|Day's Range||4.5200 - 4.8100|
|52 Week Range||3.6600 - 11.8200|
|Beta (5Y Monthly)||-1.14|
|PE Ratio (TTM)||3.61|
|Earnings Date||Aug 10, 2022 - Aug 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.33|
Subscribe to Yahoo Finance Plus to view Fair Value for CODX
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting at the H.C. Wainwright & Co. 2022 Global Investment Conference, being held in-person and virtually on May 23-26 in Miami, Florida.
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2022.
Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders might understandably be very concerned that the share price has...